Lunchtime Networking Event, Hosted by WuXi AppTec
The next edition of our 'Lunchtime Networking Event' series is being hosted by the team at WuXi AppTec at the Beehouse on Milton Park on Tuesday 8th July 2025.
In addition to the networking and delicious lunch, the event will feature presentations from the WuXi AppTec teams covering 'Drug Discoveries for New Modalities' and 'Enabling Diversity in Drug Modalities'. There will also be the opportunity to book 1:1 meetings with the WuXi AppTec teams after the lunch.
Programme:
11.15 โ 11.30 Guest arrival, registration & networking
11.30 โ 12:00 WuXi welcome & keynote presentation 1: Drug Discovery Strategies for New Modalities
- Robert Judkins, Ph.D., Director, IPM, WuXi AppTec
12:00 โ 12:30 Keynote presentation 2: Enabling diversity in drug modalities
- Dave Madge, Ph.D., VP Discovery Services, WuXi AppTec
12:30 โ 12:45 Audience Q&A
12.45 โ 13.30 Networking buffet lunch
13:30 โ 15.00 1-1 meetings in breakout room (or guests free to depart)
The event is complimentary and available on an 'apply to attend' basis.
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec's integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received an AA ESG rating from MSCI for the fourth consecutive year in 2024 and its open-access platform is enabling around 6,000 customers from over 30 countries to improve the health of those in need โ and to realize the vision that "every drug can be made and every disease can be treated."
